ANTI-ANDROGENS TREATMENT ENHANCES CYTOTOXICITY OF OXIDATIVE- PHOSPHORYLATION INHIBITORS AGAINST CASTRATION-RESISTANT PROSTATE CANCER
$1,143,016FY2020Defense Health AgencyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center